HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guanidination and nitroguanidination of staphylococcal enterotoxin B.

Abstract
Guanidination of the free amino groups of staphylococcal enterotoxin B with 3,5-dimethyl-1-guanylpyrazole converted 31-32 of 33 epsilon-amino groups and 30% of the N-terminal residue. This product, although markedly reduced in solubility, suffered no gross change in conformation and retained full biological activity. A derivative prepared by reaction with O-methylisourea with only one lysyl residue unaltered lost most of its emetic activity. Nitroguanidination with 3,5-dimethyl-1-nitroguanylpyrazole converted up to 28 of the epsilon-amino groups and essentially all of the N-terminus. This material was greatly reduced in ability to produce emesis and like the O-methylisourea prepared guanidinated enterotoxin, gave only a line of partial identity in double diffusion. The loss of activity is attributed to unfolding and it is concluded that the free amino groups of enterotoxin B do not critically participate in either its antigenic determinants or its active center for emesis.
AuthorsL Spero, H M Jacoby, J E Dalidowicz, S J Silverman
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 251 Issue 3 Pg. 345-56 (Dec 28 1971) ISSN: 0006-3002 [Print] Netherlands
PMID11452875 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Affinity Labels
  • Amidines
  • Enterotoxins
  • Indicators and Reagents
  • Methylurea Compounds
  • Superantigens
  • 3,5-dimethylpyrazole-1-carboxamidine
  • O-methylisourea
  • enterotoxin B, staphylococcal
  • Glutamic Acid
Topics
  • Affinity Labels
  • Amidines
  • Animals
  • Enterotoxins (chemistry, toxicity)
  • Glutamic Acid (chemistry)
  • Immunodiffusion
  • Indicators and Reagents
  • Kinetics
  • Lethal Dose 50
  • Methylurea Compounds
  • Staphylococcus aureus
  • Superantigens (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: